Analysis of viral strand sequence data and viral replication capacity could potentially lead to biological insights regarding the replication ability of HIV-1. Determining specific target codons on the viral strand will facilitate the manufacturing of target-specific antiretrovirals. Various algorithmic and analysis techniques can be applied to this application. In this paper, we apply two techniques to a data set consisting of 317 patients, each with 282 sequenced protease and reverse transcriptase codons. The first application is recently developed multiple testing procedures to find codons which have significant univariate associations with the replication capacity of the virus. A single-step multiple testing procedure (Pollard and van der Laan 2003) method was used to control the family wise error rate (FWER) at the five percent alpha level as well as the application of augmentation multiple testing procedures to control the generalized family wise error (gFWER) or the tail probability of the proportion of false positives (TPPFP). We also applied a data adaptive multiple regression algorithm to obtain a prediction of viral replication capacity based on an entire mutant/non-mutant sequence profile. This is a loss-based, cross-validated Deletion/Substitution/ Addition regression algorithm (Sinisi and van der Laan 2004), which builds candidate estimators in the prediction of a univariate outcome by minimizing an empirical risk. These methods are two separate techniques with distinct goals used to analyze this structure of viral data.
Introduction

Motivation
Sequencing a virus, such as the Human Immunodeficiency Virus Type 1 (HIV-1), could potentially give further insight into the genotype-phenotype associations of a virus. The replication ability of a virus is vital, especially in the case of HIV, where replication is proportional to the severity of disease. This section will provide a brief summary of the relevant biological processes.
General Biology
Viral transcription is one of the first events which occurs after infection by a DNA virus. The process consists of the virus using the host's enzyme to transcribe the viral genome by copying a DNA code into RNA. A gene which encodes a particular protein is copied into messenger RNA (mRNA), and then the mRNA is transported in the cell and subsequently proteins are manufactured (Karn, 1995; August et al., 2000) .
In the case of HIV the opposite process occurs. HIV is unusual because it has RNA as its genetic material and is not made of DNA like most viruses and cells. The reverse transcriptase enzyme reads the sequence of the virus' RNA strand and transcribes it into a complementary DNA sequence. Without this process the virus would not be able to reproduce. HIV undergoes reverse transcription to convert its RNA into a form compatible with its host's DNA. The viral RNA genome is reverse transcribed into a DNA copy, transported into the nucleus, and integrated in the host's chromosome.
The reverse transcriptase and protease regions of the virus are important areas to consider when studying the viral replication capacity of HIV-1 since they are both vital to transcription. The reverse transcriptase enzyme works in the capsid and is used to synthesize the double stranded DNA from the virus' single stranded RNA genome. In its double stranded DNA form, the virus can integrate into the host's chromosome, where it becomes the template for RNA virus strands by the host replication machinery. The protease is an enzyme that breaks the peptide bonds of proteins. The virus depends on these enzymes in its reproductive cycle, by cleaving emerging polyproteins during viral replication (August et al., 2000) .
Antiretrovirals
Since the protease and reverse transcriptase regions are important in viral replication, these areas of the virus should be analyzed when researching replication and when creating antiretroviral drugs to inhibit the replication of the virus. Multiple antiretroviral drugs have been manufactured to target these specific areas of the viral strand.
There are three main groups of anti-HIV drugs (currently being used in practice). Each of these groups attacks HIV in a different way. The first type is Nucleoside Reverse Transcriptase Inhibitors (NRTIs). As previously mentioned, HIV uses the reverse transcriptase in order to infect healthy cells and therefore reproduce. NRTIs inhibit reverse transcriptase and slow down the production of the reverse transcriptase enzyme and make HIV unable to infect cells and therefore duplicate itself (August et al., 2000) .
Like NRTIs, Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) stop HIV from infecting cells by targeting the reverse transcriptase of the virus. They block the duplication and spread of the virus (August et al., 2000) . The NRTIs and NNRTIs both target the reverse transcriptase, but the two classes of drugs differ primarily in the mode of inhibition.
Protease inhibitors inhibit the protease, which is a digestive enzyme that breaks down proteins. The protease is essential for the production of functional viral enzymes. The protease inhibitors thwart the duplication and reproduction of the virus and thus prevent the infection of new cells. Protease inhibitors are able to slow the process of an immature non-infectious virus from becoming mature and infectious (August et al., 2000; Karn, 1995) .
Mutations
Viral resistance to antiretroviral drugs, including protease and reverse transcriptase inhibitors, is partially a result of antiretroviral therapy. Resistance can be linked directly to mutations at specific amino acid positions of the reverse transcriptase and protease proteins. Mutations are often defined as differences of a virus from the consensus B reference sequence Wu et al., 2003) . Drug resistance is caused by various mutations that emerge in complex patterns. Mutations that are associated with the emergence of drug resistance may decrease the inherent capacity of the virus to replicate efficiently, its replicative capacity (Nijhuis et al., 2001) . In particular, mutations that confer resistance to protease inhibitors may decrease viral replicative capacity (Martinez-Picado et al., 1999; Zennou et al., 1998; ). During HIV-1 infection in the body, an estimated 10 8 to 10
10 new virons are produced each day Deeks, 2003) . This viral replication process accelerates viral replication. The virus' genetic diversity increases as a result of the number of new virons as well as the potential for proofreading errors of the reverse transcriptase (Sune et al., 2004) . This in combination with antiretroviral mutations increases the diversity of the virus.
The previous sections have focused on specific regions of the HIV viral strand. The reverse transcriptase and protease regions of a viral strand must be sequenced when determining specific internal drug target positions. The codon positions of these viral regions are subsequently determined. These codon positions consist of three base pairs, and each individually codes for one of the twenty possible amino acids.
Replication Assessment
Finally, in order to assess the replication of the virus, a measure of replication capacity is used. Replication capacity, generally measured ex vivo in the absence of drug, is a measure of the inherent ability of a virus to replicate in an ideal environment (Deeks, 2003) . This is an environment with many cellular targets, no exogenous or endogenous inhibitors, and no immune system responses against the virus (Barbour et al., 2002; Segal et al., 2004) .
A replication capacity (RC) measurement can provide an important measurement for viral fitness. The replicative capacity of HIV, used in these analyses, was measured with an assay where it is calculated as a ratio of the luciferase activity from an infected virus to the luciferase activity of a wild type reference virus. A ratio of less than one reflects a reduced RC as compared to that of the wild-type reference .
There are various other methods which are used to measure and quantify viral replication. These methods include quantitative assays to determine viral RNA concentration, determining the number of cells infected by HIV per day, and determining a patient's viral load or a measure of the amount of virus in one's blood.
Statistical Application to Biological Data
Given the position-specific codons of the viral strand and the replication capacity of the virus, many approaches can be used to determine important codons which may be predictive of the replication capacity of a virus. This data structure lends itself to both a multiple testing procedure as well as the application of a regression-based algorithm. Both of these techniques will be applied separately to the data set to determine codons or groups of codons which may predict replication capacity.
We will present two separate analyses with distinct goals in this paper. We will present a multiple testing procedure which controls a specific Type-I error rate at an αlevel. This will focus on the marginal associations of each codon and replication capacity, adjusting for the multiplicity of the problem. We will also present multiplicative prediction of replication capacity by using an aggressive algorithm. This algorithm performs dimension reduction by choosing a subset of covariates based on ranked univariate t-statistics. Even though this internally ranks covariates by each covariate's marginal association with the outcome, it does not control these associations at an αlevel as done with the multiple testing procedure. The regression based algorithm provides variable importance measures for each codon, based on the models fitted during the algorithm.
Previous analyses on this data set include the application of tree based methods, in particular random forests (Segal et al., 2004) . Segal et al. (2004) found tree-structured models to be effective methods when analyzing amino acid based viral sequence data. Their resulting trees illustrated three main codons which were associated with viral replication capacity, which correspond to the first three partitions of their tree. These codons will be discussed in Section 3.
Methods
Data Structure
The HIV-1 sequence dataset consists of 317 records linking the replication capacity (RC) with the reverse transcriptase (RT) and protease (PRO) sequence data from individuals participating in studies at the San Francisco General Hospital and Gladstone Institute of Virology (Segal et al., 2004) . The protease positions 4-99 and reverse transcriptase positions 38-223 of the viral strand are used. Each of these codon positions contains three base pairs, which in turn codes for an amino acid. At each position there are usually a majority of patients exhibiting one amino acid as compared to the other possible amino acids at that position. There are 282 covariate positions with the number of possible amino acids ranging from 1-10, with a median of 4 amino acids per position.. The outcome is a continuous measure of replication capacity ranging from 0.261 to 151.
The positions were coded as binary covariates with each codon position corresponding to either a mutation or no mutation. The value zero represents the majority of individuals with one specific amino acid, and the value one represents all of the individuals exhibiting other amino acids at that position, therefore the minority of individuals. Most individuals therefore exhibit one specific amino acid at each position. The position rt178 was somewhat ambiguous since two of the amino acids were exhibited by a majority of the individuals. In order to accurately code this position, we referred to biological research which indicates that the subtype B consensus amino acid at that position is I (isoleucine) and the mutations are L (leucine), M (methionine), and V (valine) (see http://hivdb.stanford.edu/cgi-bin/RTMut.cgi). This procedure of coding the positions as mutant/non-mutant has been performed in several other analyses of HIV-1 data (Wu et al., 2003; . The natural log of the outcome of replication capacity is used in all of the following analyses. This will allow for a more accurate interpretation of the results, since this transformation will decrease the impact caused by the extreme outliers.
We will define the observed data structure for a subject i as O i = (Y i , W i ), i = 1, ..., n (n = 317 individuals), where W i = (W 1i , . . . , W pi ) is a p-vector of explanatory variables (e.g., codon positions), and Y i is the scalar outcome (e.g., log replication capacity).
Statistical Analysis
Multiple Testing Procedure
A multiple testing procedure is applied to the data set to test each codon position with the outcome of the natural log of the replication capacity. The testing approach creates a null distribution for the test statistics as opposed to a null data-generating distribution. In the following section we outline the steps used in this procedure, which includes: defining the test statistics, null hypotheses and parameter of interest; defining the error rate which we wish to control; defining the null distribution of the test statistics Q 0 with a resampling/bootstrap approach; and finally creating adjusted p-values for the M tests.
We perform simple linear regressions of replication capacity against the specific codon, and estimate E(Y |W m ), where m = 1, ..., M corresponds to the M codon positions. For each m-specific linear regression, the parameter of interest is the coefficient of the codon, β 1 (m). The null hypothesis for each of these M tests is a two-sided hypothesis, since we are interested in large absolute values of the test-statistic. In this case, the null hypothesis is: H 0m :β(m) =β 0 (m), with β 0 (m) = 0, and the alternative hypothesis is H 1m :β(m) =β 0 (m). The corresponding test-statistic is defined as:
, where
is the estimated standard error of the least squares estimator β n (m). The hypothesis H 0m is rejected if T n (m) > c(m). c(m) is selected to control a desired Type I error under an appropriate null distribution for T n (m), where m = 1, ..., M. In the process of establishing the validity of the multiple testing procedure, one needs to assume that β n (m) is an asymptotically linear estimator of β(m) (Pollard and van der Laan, 2003) , which naturally holds for the least squares estimator. The latter conditions allow application of the central limit theorem so that (n)(β n (m) −β(m)) is normally distributed. We can define this multiple testing procedure (i.e. a set of rejections) as S n = (m : T n (m) > c n (m)) First, we define the error rate that we wish to control. We consider three types of Type I error rates: family-wise error rate, generalized family-wise error rate, and tail probability of the proportion of false positives. We are interested in controlling these three error rates, separately, at the 5-percent α-level.
The family-wise error rate (FWER) is defined as the probability of at least one Type I error, given a multiple testing procedure S n . The FWER error rate θ(F Vn ) is a function of the distribution F Vn , where V n is the number of false positives resulting from the multiple testing procedure S n , and therefore
The number of false positives can be defined as V n = |S n ∩ S 0 |, where S 0 are the null hypotheses. The generalized Family-Wise Error Rate (gFWER) is the probability of at least k + 1 Type I errors. This error rate is defined as: gF W ER(k)≡P r(V n > k) = 1−F Vn (k). When k = 0, the gFWER is equal to the previously defined family-wise error rate, FWER. Finally, the tail probability of the proportion of false positives (TPPFP) is based on controlling the probability of the proportion false positives (V n ) to the total number of rejected hypotheses (S n ), at a user supplied q and αlevel. This error rate is therefore a function of the joint distribution of the number of false positives and rejections. T P P F P (q)≡ P r(V n /R n > q), where q ∈ (0, 1).
Secondly, we generate a null distribution. The estimated null distribution is used to derive a common cut-off value c o for the test statistics T n (m) such that a given Type I error rate (described above) is controlled at a specific user defined level α. Pollard and van der Laan (2003) proposed as the null distribution the asymptotic distribution of the mean-zero centered test statistics, or equivalently the asymptotic distribution of ( (n)(β n (m) − β(m)) : m). This null distribution can be estimated with the bootstrap distribution of
(where i.e. β # n (m) corresponds to β n (m) calculated from a bootstrap sample). They proved that with this null distribution the single-step procedures based on the common cut-off rules for each test statistic, T n (m), provide asymptotic control of any Type I error rate that is a function of the distribution of the number of false positives, V n . This approach is generalized to general test statistics for general null hypotheses of the form H o,j : P o ∈ M j , where M j is an element of a specific statistical model (Dudoit et al., 2004) .
As described in detail in Pollard and van der Laan (2003) and Dudoit et al. (2004) , the bootstrap method can be implemented as follows: Initially, one generates B bootstrap samples, (X
., M, which is arranged in an M × B matrix. This matrix will be denoted as T # n , with rows of this matrix corresponding to the M hypotheses and the columns correspond to the B bootstrap samples. The row means E[T n (m)] of the matrix are computed, and the matrix is shifted by the respective means. This matrix represents a sample from a null distribution Q 0,n . After calculating the bootstrap matrix, one can easily obtain the common cut-offs, c 0 , for controlling family-wise error (FWER) control. For FWER control (k = 0), the general procedure is summarized as the singlestep maxT procedure, based on the maximum test statistic for each column in the Q 0n matrix. The estimated common cut-off value c o is the (1 −α) quantile of the B-vector of maximum values, obtained from the estimated bootstrapped distribution. This now defines a Multiple Testing Procedure S n,F W E (T n , Q 0n ,α) ⊂ (1, ..., M), which is based on the test statistics, null distribution, and α. Once one defines this multiple testing procedure controlling FWER, we can apply simple augmentation procedures in order to control the generalized family wise error (gFWER) or the tail probability of the proportion of false positives (TPPFP), which was outlined in van der Laan et al. (2004) . We will define the initial set of rejections of size r 0 corresponding with a multiple testing procedure controlling FWER at level α. In the case of gFWER(k), the augmentation procedure automatically rejects the next k hypotheses. In the case of TPPFP one simply adds the next q 1−q r 0 most significant tests to the rejection set to control TPPFP(q) at level α.
Adjusted p-values
Adjusted p-values define multiple testing procedures for all levels of α. We will outline the adjusted p-values associated with the FWER controlling procedure, as well as those resulting from the augmentation. Given a Multiple Testing Procedure S θ (T n , Q 0 ,α), the adjusted p-values for each of the M tests are defined as follows. The adjusted p-value˜P n (m) =˜P(m, T n , Q 0 ), for null hypothesis H 0m , is defined as:
We note that the adjusted p-values are defined as˜P n (m) =˜P(m, T n , Q 0n ), therefore based on the test statistics and null distribution. Since we are controlling the FWER and using the maxT approach, we can calculate thesẽ P values from the distribution of the vector of maximum values.
Once we obtain the adjusted p-values controlling FWER, we used simple augmentation techniques to control generalized family wise error (gFWER) and the tail probability of the proportion of false positives (TPPFP) (van der Laan et al., 2004) . Therefore we will have three separate adjusted p-values for each test, corresponding to FWER, gFWER(k), and TPPFP(q) control.
In order to control the generalized family wise error, the simple augmentation procedure consists of initially ordering the M FWER adjusted p-values from smallest to largest, P 0n (O n (1)) ≤·· ·≤P 0n (O n (M)), with O n (m) denoting the indices for the ordered unadjusted p-values P 0n (m). The augmentation procedure used to control gF W ER(k) will set the first k ordered FWER adjusted p-values equal to 0 and the ordered FWER adjusted p-values of m = k + 1, ..., M will result in the offset (by k) of the ordered FWER adjusted p-values. Therefore the k + 1 ordered FWER adjusted p-value is then equal to the first ordered FWER adjusted p-value, the k + 2 ordered FWER adjusted p-value is equal to the second ordered FWER adjusted p-value, and so on until the M th ordered FWER adjusted p-value (equal to the M − k ordered FWER adjusted p-value). This process can be summarized as follows:
Additional information on this augmentation can be found in van der Laan et al. (2004) .
When controlling the tail proportion of the number of false positives (TPPFP), the ordered FWER adjusted p-values (defined above) are again used with a user defined q or proportion of false positives to total rejections. The m th ordered FWER adjusted p-value is shifted by m × q, instead of m − k as indicated in the gFWER procedure. Again, in more formal terms, the augmentation procedure produces adjusted p-values that are defined as (van der Laan et al., 2004) :
D/S/A Algorithm
The Cross-validated Deletion/Substitution/Addition (D/S/A) algorithm (Sinisi and van der Laan, 2004) is a data-adaptive machine learning methodology, which, in particular, can be used to predict the conditional expectation of an outcome or response, Y , given a set of inputs or explanatory variables, W , where W is a d-dimensional vector. The algorithm estimates the minimizer of an expectation of a loss function L(O, ψ) over the parameter space for the parameter of interest ψ 0 . Sinisi and van der Laan (2004) implemented this algorithm for the regression case, where the loss function is the squared
and the parameter of interest is E(Y |W ).
Given the choice of loss function, the algorithm requires specification of the choice of basis functions, or more general, the particular way aimed to parametrize the space of all allowed functions of W . In the implementation of Sinisi and van der Laan (2004) , the basis functions are tensor products of polynomials powers. Examples of such a basis function in this context for binary data is a main term W 1 , a two-way interaction W 1 W 2 , a three-way interaction W 1 W 2 W 3 . In addition, one needs to specify the fine tuning parameters which define the allowed set of regressions (i.e., a subparameter space of the parameter space consisting of all functions of W ). In the implementation used for our data analysis, the fine tuning parameters are the size k 1 (i.e., number of basis functions), a dimension reduction of W to a vector of size k 0 described below, and the order k 2 of the interactions. For each choice of k = (k 0 , k 1 , k 2 ), the algorithm computes an estimator which is a linear regression with k 1 interaction terms of maximal order k 2 . We refer to these k-specific estimators as the candidate estimators. Formally, the algorithm builds an estimator,ˆΨ k=(k 0 ,k 1 ,k 2 ) (P n ), a function of the empirical data, which is indexed by certain fine tuning parameters (k 0 , k 1 , k 2 ). These fine-tuning parameters are selected with V -fold cross-validation: that is, our final estimator isˆΨ k CV (Pn) (P n ), where k CV (P n ) is the choice of k which minimizes the cross-validated risk of the k-specific estimatorˆΨ k (P n ) over all allowed k's.
The algorithm carries out a separate minimization problem for each choice of k 0 , k 2 , where the objective function is the empirical mean of the loss function, which in this case is just the Residual Sum of Squared Errors (RSS). For a given k 0 , k 2 , the algorithm involves a running model from which it carries out local searches, and it keeps track of the best fits of size k 1 for all k 1 . Specifically, the algorithm can be described in the following manner: given a current estimator indexed by k 1 , which in this case is represented by a linear regression fit of k 1 polynomial basis functions, a deletion move corresponds to deleting a term from the model. If this move improves the RSS as compared to the best estimate at size (k 1 − 1), the algorithm updates the best fit at size (k 1 − 1) to this new fit, and moves the running model to this smaller model. A substitution move corresponds to replacing one of the terms in the model with another polynomial basis function. Again, if this move produces a model with a lower RSS, the algorithm updates the best fit of size k 1 to this new fit, and moves the running model to this new fit. Finally, an addition move is performed only when the deletion and substitution moves do not improve the comparable RSS. An addition move will add another polynomial basis function and in turn if this move is an improvement, it will update the fit of size (k 1 + 1). This process is repeated for all choices of k 0 and k 2 .
We will outline these moves in detail below, and define the fine tuning parameter k 0 , which indexes the estimator.
Estimator Construction: Deletion, Substitution, and Addition Moves
To use the D/S/A algorithm for polynomial regression, the user feeds the data (Y, W ) and specifies a set of constraints over which to search: (WˆR (1) , . . . , WˆR (k 0 ) ), of length k 0 , as the vector of covariates into the D/S/A algorithm. This constraint was placed in hopes to eliminate much of the noise and possible competition of variables in predicting the outcome. Therefore we will be including those variables with strong marginal associations with the outcome.
The algorithm starts by fitting a linear regression with the main term, W 1 or W 2 or, . . . , W k 0 , that minimizes the squared error loss. Next, it will begin cycling through a set of deletion, substitution, and addition moves (Sinisi and van der Laan, 2004 ). As noted above, the goal of each step of the algorithm is to find the best estimator indexed by k = (k 0 , k 1 , k 2 ), i.e., find the linear combination of polynomial basis functions which best predicts Y by minimizing the empirical mean squared error loss function. These moves are restricted by k 0 , k 1 , and k 2 thereby yielding estimators with a maximum of k 1 terms, k 2 -way interactions, and searching from a set of k 0 possible covariates. The algorithm gives preference to deletion moves, then substitution moves, then addition moves. The algorithm will try a deletion move first, and if there is no deletion move which improves the current best RSS for the fit of the same dimension, then the algorithm will try a substitution move. If it can make a substitution move, it will go back and try another deletion move.
Otherwise, it will finally try an addition move. If it makes an addition move, it goes back to trying the deletion moves. The algorithm will stop making addition moves when the maximum K 1 is reached or when there is no improvement in the RSS, i.e., the difference between the RSS of the best estimator of a certain size and a new estimator of that same size is no greater than a user defined value. Meanwhile, the algorithm is keeping track of the best estimators for all possible k.
To illustrate the deletion, substitution, and addition moves, suppose that k 0 = 4, W = (W 1 , . . . , W 4 ), and that the current fit in the D/S/A algorithm is given by Y = W 1 + W 2 W 4 . Note that the current size is k 1 = 2 and the covariates are binary, as is the case for our data application, so that W 1 = W 2 1 , and we are only allowing three-way interactions k 2 = 3.
A deletion move simply means removing one of the terms of the current estimator and fitting an estimator of size k 1 − 1.
The substitution moves involve replacing the j th term for j = 1, . . . , k 1 with a new term, keeping the size of the estimator fixed at k 1 . The possible substitution moves are given by:
If none of these substitution moves improve RSS, then the D/S/A algorithm finds the best fit among the following addition moves:
For general notation on the three moves, refer to Sinisi and van der Laan (2004) .
After the algorithm cycles through the moves for a specified range of k = (k 0 , k 1 , k 2 ) values, it results in a three-dimensional matrix of candidate estimators (ˆΨ k 0 ,k 1 ,k 2 (P n )) indexed by k 1 , k 2 , and k 0 . To select amongst these estimators, the algorithm employs cross-validation.
Estimator Selection: Cross-Validation
Cross-validation splits the data, or learning set, into a training set and validation set. In particular, we are using V -fold cross-validation and splitting the data into V training sets and V corresponding validation sets. The algorithm builds estimatorsˆΨ k 0 ,k 1 ,k 2 for all choices of k 0 , k 1 , and k 2 on each of the training sets, and evaluates, i.e., computes a cross-validated risk, these estimators on the corresponding validation set.
The values of (k 0 , k 1 , k 2 ) that correspond to the minimal cross-validated risk are selected and labeledk 0 ,k 1 ,k 2 or k CV (P n ). The algorithm is now run on the learning set with k 0 =k 0 , k 2 =k 2 , and the best estimator of sizek 1 is reported.
Variable Importance Measures
In addition to reporting an optimal predictive estimator, the D/S/A algorithm produces an importance measure for each variable. Sinisi and van der Laan (2004) proposed a derivative-based method to estimate importance measures for individual variables based on the idea of counterfactual variables in the causality literature (van der Laan and Robins, 2003) . Measures of variable importance can assist in the identification of a subset of codons for replication capacity.
Let the data be n observations of (Y, W ), where Y is the outcome of interest and W is a d-dimensional vector of covariates for which we would like a measure of importance. Let h(W ) = E(Y |W ). Sinisi and van der Laan (2004) The final estimate of the importance measure is then a weighted average of α b (j) across many b-specific fits. Various approaches for obtaining b-specific fitsĥ b can be considered. The approach we employed is to use the fits for all models of size k 1 andk 0 ,k 2 made by the D/S/A algorithm to estimateα(j).
Let S b ∈ {1, . . . , d} identify the subset of variables used in a b-specific fit. Then for a given variable, its importance measure is estimated across fits as:
In equation (3), wt represents a weight for a particular fit. We let the weights equal RSS/(n − p) where n represents the number of observations and p represents the number of parameters in the fitted model. Table 1 presents a list of codon positions that we refer to in Tables 2 -4 and throughout this section. In these tables pr55, for example, refers to Kpr55G/R where we are implying that the mutant amino acids for this position are G (glycine) or R (arginine) and the wild type amino acid is K (lysine). When looking at our results, refer to Table 1 to determine which amino acids are mutant or wild type.
Results
Summary of Previous Results
Sequencing the reverse transcriptase and protease positions of the HIV-1 viral strand is an important method used to determine target areas for antiretroviral therapy. The reverse transcriptase and protease enzymes, coded by these regions, facilitate the replication of HIV-1 virus. Sequencing these regions provides biologists with a greater understanding of the genetic mechanism behind the resistance to antiretroviral drugs. It is important not only to 
look at the individual effect of these mutations on the outcome of replication capacity but also to look at potential interaction effects between mutations.
The reverse transcriptase is a DNA polymerase that uses RNA or DNA as its primer. This enzyme is responsible for producing the double stranded DNA copy of the single strand of RNA found in the virus. This double stranded DNA copy of the viral information is inserted into the host's DNA, where it can be replicated. This viral enzyme has often been the focus of medical research, since it is the target of two major drug classes, NRTI and NNRTI. Reverse transcriptase inhibitors inhibit the polymerase reaction, which causes the manufacturing of the double stranded DNA. Several codon position mutations are related to antiretroviral resistance and viral replication capacity (i.e. positions rt184, rt215, rt41, rt210, rt116, rt65, rt67, and rt69) (Shafer et al., 2001 ). We will mention several of these important positions. Examples of such mutations include rt41, where Mrt41L increases AZT resistance when present with a T rt215Y/F mutation. A popular codon position, Mrt184V/I, partially suppresses the T rt215Y mediated AZT resistance. This mutation often causes a low-level resistance to the antiretrovirals didanosine and zalcitabine. Mrt184V also reduces replication capacity by reducing the ability of the reverse transcriptase to process correctly. Viruses that contained the M184V mutation were not able to undergo compensatory mutagenesis and reestablish wild-type replication kinetics, viruses that did not contain M184V mutated extensively. Scientists want to deliberately select for this mutation with antiretroviral drugs to slow down replication since this mutation does not allow the virus to restore itself to full replication (Prado et al., 2002) .
Additionally, mutations at positions of the reverse transcriptase rt41, rt184, rt215 among others have shown resistance to NRTIs (Shafer et al., 2001) . Reverse transcriptase positions rt215, rt184, and rt41 have the largest resistance to AZT, as compared to other RT positions. Reverse transcriptase position rt70 mutations also causes resistance to AZT when there are amino acid changes at Krt70R, followed by T rt215F/Y , Mrt41L, Drt67N, and Krt219Q (Goudsmit et al., 1997) .
The protease is an enzyme that is responsible for the post-translation processing of the Gag and Gag-Pol polyproteins, therefore producing the structural proteins and enzymes of the virus. Several mutations in certain positions have been found to have an impact on resistance of the virus (codons: pr54, pr53, pr46, pr47, pr48, pr50, pr36, pr77, pr82, pr32, pr84, pr20, pr30, pr24, pr73, pr88, pr10, pr90, pr93, pr71, pr63) (Shafer et al., 2001 ). Mu-tations at several protease cleavage sites also contribute to drug resistance. An example of a protease mutation is position pr10, where Lpr10I/F/V/R, one of the most common mutations, is associated with resistance to all protease inhibitors when present with another mutation. Position pr90 has an impact on the substrate cleft of the virus and L90M causes resistance to saquinavir when combined with various other mutations (Shafer et al., 1998) . For example, the Gpr48V /Lpr90M double mutation has shown delayed viral replication, whereas Lpr90M alone had a higher replication capacity (Sune et al., 2004) . Position Ipr54V/L/T also causes resistance to the other protease inhibitors when present with other mutations. Mutations at residues pr54 and pr82 produce resistance to Indinavir and Ritonavir. Additionally, mutations within V pr82A, Ipr84V , and Lpr90M have been associated with a median change in replication capacity (Barbour et al., 2002; Shafer et al., 2001) .
Mutations at any of these previously mentioned positions decrease replication capacity and cause defects in polyprotein processing (August et al., 2000) . A mutation at protease position pr47 is associated with amprenavir resistance (Prado et al., 2002) . The accumulation of protease Ipr47V mutation increased amprenavir and lopinavir resistance but reduced viral replication capacity. Many studies show that the addition of Mpr46I and Ipr47V improves the replication of Ipr50V mutant viruses (Prado et al., 2002) . In summary, protease positions pr10, pr46, pr48, pr54, pr63, pr71, pr82, pr84, and pr90 cause resistance to saquinavir alone or in combination with AZT (Prado et al., 2002); protease positions pr20, pr33, pr36, pr46, pr54, pr63, pr71, pr82, pr84 , and pr90 cause ritonavir resistance; protease positions pr10, pr20, pr24, pr32, pr46, pr54, pr63, pr64, pr71, pr82, pr84 , and pr90 cause resistance to indinavir; and finally protease positions pr30, pr36, pr46, pr71, pr77, and pr84 cause resistance to nelfinavir.
Finally, as previously alluded to, replication capacity is a convenient method used to measure a virus' ability to replicate. This measure is often used when assessing the previously mentioned mutations. The method is described as a modification of the phenotypic drug susceptibility test (Barbour et al., 2002) . The patient-specific gene sequences of the protease and reverse transcriptase are inserted into a virus which contains the luciferase gene (Barbour et al., 2002) . The virus is allowed to replicate in this environment and the luciferase activity is measured and compared to the reference virus, which has reverse transcriptase and protease sequences from a known strain of the HIV-1 virus. The HIV-1 virus has been shown from biological research to have a broad range of replication capacity values. These values are useful measures when assessing various aspects of the virus (Barbour et al., 2002) . Segal et al. (2004) applied various methods to data similar to the type used in this article, with 336 observations involving repeated measurements and 276 positions, and provide results given by a tree-structured method (rpart), random forests, and logic regression. Segal et al. (2004) (2004) give a tree with further splits. The top two splits are rt184 and rt215 which correspond to primary drug resistance sites known to affect replication capacity. Segal et al. (2004) suggest that the third split on rt178 is interesting in terms of novelty. Segal et al. (2004) provide a schematic representation of position importance measures for the random forest with minimal prediction error. rt184 and rt215 are the most prominent where rt184 has an importance measure of close to 8 and rt215 has an importance measure close to 1. Finally, the fitted LR model is given by one tree with three leaves: rt184, rt215, and rt178. Segal et al. (2004) discuss that though rt178 is in the LR model and shown in their TSM, it is not given high importance by RF, and the TSM achieving minimum cross-validated prediction error is that with just one split (rt184). Table 2 displays the adjusted p-values controlling for FWER (maxT approach) for 17 codon positions, and Figure 1 plots the sorted adjusted pvalues controlling for FWER, gFWER, and TPPFP. The FWER adjusted p-values were calculated, as described in the Methods section, and two simple augmentations were separately applied to control the TPPFP and gFWER at a level q = 0.1 and k = 5, respectively (additional levels of q and k are presented in Figure 1 ).The gFWER augmentation, in this case, first orders the 282 FWER adjusted p-values and sets the first five (k) FWER adjusted p-values to 0. The sixth ordered FWER adjusted p-value is then equal to the m − k, or first, FWER adjusted p-value, the seventh ordered FWER adjusted p-value is equal to the second FWER adjusted p-value, and so on until the M th ordered FWER adjusted p-value (equal to the 277 th FWER adjusted p-value). The TPPFP(q = 0.1) augmentation procedure first orders the 282 FWER adjusted p-values. The m th ordered FWER adjusted p-value is shifted by m × q, instead of m − k as outlined in the gFWER procedure.
Multiple Testing Procedure
The multiple testing procedure illustrated several codon positions that were significant after controlling for the family wise error rate. Positions such as rt184, rt215, rt41, pr54, pr46, pr47, pr32, pr90, pr82, pr10 and pr71 have been confirmed in previous work as significant positions with respect to replication capacity and/or antiretroviral resistance (Segal et al., 2004; Shafer et al., 2001) . As mentioned in section 3.1, a majority of the most significant codons are supported biologically by previous research. The specific mutations present in our dataset also parallel those found in previous biological research (Table 1) . For example, Ipr54V/L/T, Mpr46I, V pr32I, Lpr90M, V pr82A/T /F/S, Apr71V/T, and Lpr10I/F/V/R are all protease positions in which mutations increase the resistance to various protease inhibitors. Mutations at several of these positions also have an impact on the replication capacity of the virus. Reverse transcriptase mutation at position Mrt41L increases AZT resistance when present with T rt215Y/F. In addition, Mrt184V/I suppresses T rt215Y , thus decreasing the AZT resistance (Shafer et al., 2001 ). This illustrates one of complex mutation processes which occurs between these codons. Other codon positions such as pr32 and pr34 and pr54 and pr55 are neighboring codons, respectively, and therefore these mutations, in association with replication, could potentially be of interest for future biological research.
Results from the D/S/A Algorithm
As a result of the multiple testing procedure, several codons had an adjusted FWER p-value less than the αlevel of 0.05. This multiple testing procedure created a subset of codons with strong marginal associations with the outcome of replication capacity. We had initially thought of applying the D/S/A algorithm to this subset of codons, in hopes to eliminate the noise, which is often present in regression models with many predictor variables. We realized that by using this subset, created outside of the D/S/A algorithm's framework, we could be introducing bias in our final model. This is because we are a priori predetermining the subset of variables with strong univariate associations (not necessarily choosing these positions because of prior biological knowledge). The bias is introduced since we would not be cross-validating (in the D/S/A algorithm) on the full data, and therefore only a small subset of the data, which was chosen by the multiple testing procedure, thus not performing honest cross-validation.
Instead we reduced the number of predictor variables by allowing the D/S/A algorithm to select k 0 with cross-validation, where k 0 is based on univariate associations between a single predictor and the outcome. The D/S/A algorithm was applied to the dataset and cross-validation was used to select: (1) k 1 and k 2 and (2) k 0 , k 1 , and k 2 , as discussed earlier, where k 0 represents the number of initial codon variables to be used as input in the model (dimension of vector of covariates), k 1 represents the size of the final regression model, and k 2 represents the maximum order of interaction for each tensor product. We ran the algorithm such that v = 5, in our v-fold cross-validation scheme, k 0 = 282 or k 0 = {1, . . . , 282}, k 1 = {1, . . . , 10}, and k 2 = {1, . . . , 4}.
The final results, using the log replication capacity as the outcome, given by the D/S/A algorithm are displayed in Table 3 . With constraints imposed only on k 1 and k 2 , the final fitted model consists of ten terms (k 1 = 10) where the maximum order of interaction is two (k 2 = 2). When we imposed three constraints, the D/S/A algorithm reduced the data to the top nine codons (k 0 = 9) and produced a model with seven terms (k 1 = 7) where the maximum order of interaction again is two (k 2 = 2). This model has potentially important biological implications. First, rt184 is illustrated in this model. A rt184 mutation is known from previous research (Segal et al., 2004) to be important in the replication capacity of a virus. A mutation in rt184 causes full viral replication to be thwarted. The codon Mrt184V/I will decrease replication capacity, as confirmed by the negative coefficient in the models. As mentioned in Section 3.2, many of these codon mutations are biologically important with respect to viral replication capacity and antiretroviral resistance. Protease position Lpr90M is known to have an impact on the substrate cleft and has been shown to confer resistance. The interaction terms which are found in the models could be of biological interest. For example, V pr32I is a substrate cleft and has been shown to have a minimal effect on resistance. Protease position pr32 is interacting with other protease positions in both reported models, which could be of biological interest (Shafer et al., 2001 ). The importance measures and proportion of times that codon was used in all the fits made by the D/S/A algorithm for 282 codon positions are displayed in Table 4 . Those codons not present in the table had an importance measure of zero. These were calculated for all models fitted by the algorithm for the 282 codon positions using equation (3) for binary covariates. The results (Table 4) highlight rt139, pr32, and rt184 as important variables, among others, within this data set. Again, as mentioned in previous sections, a majority of the mutations illustrated in the table have important biological implications to replication capacity and/or antiretroviral resistance, including a mutation at position rt184.
The importance measures for Model 2, or a subset of 9 codon positions are presented in Table 5 . This model eliminates some of the noise of the Model 1 regression by including a subset of variables with strong univariate associations with the outcome. Again pr32 and rt184 appear to have high variable importance measures. In both tables, pr32 has a proportion of one meaning that it was used in every fit. We eliminate some of the codons which appear in Table 4 , which could be noise, and pick up other potentially important codons, such as pr47. Mutations in pr32 and pr47, from previous 
Discussion
As illustrated in these analyses, specific codons, or areas on the viral strand, have important univariate associations with the log of the replication capacity or predictive power in determining a virus' replication capacity. We have presented two separate methods to analyze this viral strand data. The first of which was a multiple testing method, separately controlling FWER, gFWER and TPPFP, which elucidated those codons with strong marginal associations with the outcome of replication capacity. As discussed above, many of these codons with an adjusted p-value less than 0.05, controlling FWER, have been shown to be biologically important with replication capacity and/or antiretroviral resistance. The method of multiple testing was used to determine significance amongst codons, while adjusting for the multiplicity of the tests at a specific αlevel. We then applied a data-adaptive regression algorithm, the D/S/A algorithm. This method was important to look at a different question, multivariate prediction of replication capacity. This algorithm used the marginal univariate t-statistics in a different fashion, by initially ordering the codons by these values and then using crossvalidation to determine a subset of predictor variables. It is important to note that, while many of our results agree with previous research (mentioned earlier), the breadth of our biological findings may be limited as a result of the data and coding we decided to use. This paper is thus intended as an illustration of methods available for analyzing this type of data structure. The results from these two methods are not necessarily comparable. The multiple testing procedure provides insight into the marginal associations of each codon and the RC, where as results from the D/S/A algorithm focus on the prediction of RC with a subset or all of the codons from the dataset. It has been described earlier that Segal et al. (2004) detected three codons with a tree-structure method, coded by its individual amino acids, and with Logic Regression, coded by contrast indicators, but not all three were given the same importance with Random Forests. We found some of the same codons with our analyses. It is important to note the differences in both methodologies as well as data and coding between our analyses. Our multiple testing procedure did yield an adjusted p-value of less than 0.001 for rt184 and rt215. The two models displayed from the D/S/A algorithm (Table 3) include rt184 and many of the covariates are included in the top 17 codons controlling for FWER ( Table 2) .
The methods presented in this paper will hopefully be of interest to biologists studying the HIV-1 virus. We chose to create binary predictors but could have used discrete predictors by taking into account the specific amino acids at each position. Previous analyses on this type of data involved repeated measurements for several patients. We did not have repeats in our data, however future datasets of this kind may involve repeated measures. The D/S/A algorithm for univariate prediction can be generalized to apply to repeated measure outcomes. On final note, we have presented two possible techniques to analyze this data structure, however, we could have also applied the methods outlined in Segal et al. (2004) , e.g., LR and TSM. Ideally we would recommend applying all procedures and selecting amongst these with an appropriate selection criteria.
